These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
790 related articles for article (PubMed ID: 28905486)
1. Peri-operative allogeneic blood transfusion does not adversely affect oncological outcomes after radical cystectomy for urinary bladder cancer: a propensity score-weighted European multicentre study. Vetterlein MW; Gild P; Kluth LA; Seisen T; Gierth M; Fritsche HM; Burger M; Protzel C; Hakenberg OW; von Landenberg N; Roghmann F; Noldus J; Nuhn P; Pycha A; Rink M; Chun FK; May M; Fisch M; Aziz A; BJU Int; 2018 Jan; 121(1):101-110. PubMed ID: 28905486 [TBL] [Abstract][Full Text] [Related]
2. Impact of peri-operative blood transfusion on the outcomes of patients undergoing radical cystectomy for urothelial carcinoma of the bladder. Kluth LA; Xylinas E; Rieken M; El Ghouayel M; Sun M; Karakiewicz PI; Lotan Y; Chun FK; Boorjian SA; Lee RK; Briganti A; RouprĂȘt M; Fisch M; Scherr DS; Shariat SF BJU Int; 2014 Mar; 113(3):393-8. PubMed ID: 24053618 [TBL] [Abstract][Full Text] [Related]
3. Restrictive transfusion in radical cystectomy is safe. Syan-Bhanvadia S; Drangsholt S; Shah S; Cai J; Miranda G; Djaladat H; Daneshmand S Urol Oncol; 2017 Aug; 35(8):528.e15-528.e21. PubMed ID: 28476526 [TBL] [Abstract][Full Text] [Related]
4. The impact of perioperative blood transfusion on cancer recurrence and survival following radical cystectomy. Linder BJ; Frank I; Cheville JC; Tollefson MK; Thompson RH; Tarrell RF; Thapa P; Boorjian SA Eur Urol; 2013 May; 63(5):839-45. PubMed ID: 23332883 [TBL] [Abstract][Full Text] [Related]
5. Peri-operative allogeneic blood transfusion and outcomes after radical cystectomy: a population-based study. Siemens DR; Jaeger MT; Wei X; Vera-Badillo F; Booth CM World J Urol; 2017 Sep; 35(9):1435-1442. PubMed ID: 28213861 [TBL] [Abstract][Full Text] [Related]
6. The prognostic impact of perioperative blood transfusion on survival in patients with bladder urothelial carcinoma treated with radical cystectomy. Lee JS; Kim HS; Jeong CW; Kwak C; Kim HH; Ku JH Korean J Urol; 2015 Apr; 56(4):295-304. PubMed ID: 25874043 [TBL] [Abstract][Full Text] [Related]
7. Perioperative Transfusion of Leukocyte-depleted Blood Products in Contemporary Radical Cystectomy Cohort Does Not Adversely Impact Short-term Survival. Chipollini JJ; Tang DH; Patel SY; Garcia-Getting RE; Gilbert SM; Pow-Sang JM; Sexton WJ; Spiess PE; Poch MA Urology; 2017 May; 103():142-148. PubMed ID: 28011275 [TBL] [Abstract][Full Text] [Related]
8. Perioperative management and oncological outcomes following radical cystectomy for bladder cancer: a matched retrospective cohort study. Weingarten TN; Taccolini AM; Ahle ST; Dietz KR; Dowd SS; Frank I; Boorjian SA; Thapa P; Hanson AC; Schroeder DR; Sprung J Can J Anaesth; 2016 May; 63(5):584-95. PubMed ID: 26850064 [TBL] [Abstract][Full Text] [Related]
9. Blood Transfusion is Associated with Increased Perioperative Morbidity and Adverse Oncologic Outcomes in Bladder Cancer Patients Receiving Neoadjuvant Chemotherapy and Radical Cystectomy. Chalfin HJ; Liu JJ; Gandhi N; Feng Z; Johnson D; Netto GJ; Drake CG; Hahn NM; Schoenberg MP; Trock BJ; Scott AV; Frank SM; Bivalacqua TJ Ann Surg Oncol; 2016 Aug; 23(8):2715-22. PubMed ID: 27012987 [TBL] [Abstract][Full Text] [Related]
10. The relationship between perioperative blood transfusion and overall mortality in patients undergoing radical cystectomy for bladder cancer. Morgan TM; Barocas DA; Chang SS; Phillips SE; Salem S; Clark PE; Penson DF; Smith JA; Cookson MS Urol Oncol; 2013 Aug; 31(6):871-7. PubMed ID: 21906965 [TBL] [Abstract][Full Text] [Related]
11. Effectiveness of Adjuvant Chemotherapy After Radical Cystectomy for Locally Advanced and/or Pelvic Lymph Node-Positive Muscle-invasive Urothelial Carcinoma of the Bladder: A Propensity Score-Weighted Competing Risks Analysis. Vetterlein MW; Seisen T; May M; Nuhn P; Gierth M; Mayr R; Fritsche HM; Burger M; Novotny V; Froehner M; Wirth MP; Protzel C; Hakenberg OW; Roghmann F; Palisaar RJ; Noldus J; Pycha A; Bastian PJ; Trinh QD; Xylinas E; Shariat SF; Rink M; Chun FK; Dahlem R; Fisch M; Aziz A; Eur Urol Focus; 2018 Mar; 4(2):252-259. PubMed ID: 28753775 [TBL] [Abstract][Full Text] [Related]
12. Patterns and timing of perioperative blood transfusion and association with outcomes after radical cystectomy. Diamantopoulos LN; Sekar RR; Holt SK; Khaki AR; Miller NJ; Gadzinski A; Nyame YA; Vakar-Lopez F; Tretiakova MS; Psutka SP; Gore JL; Lin DW; Schade GR; Hsieh AC; Lee JK; Yezefski T; Schweizer MT; Cheng HH; Yu EY; True LD; Montgomery RB; Grivas P; Wright JL Urol Oncol; 2021 Aug; 39(8):496.e1-496.e8. PubMed ID: 33551249 [TBL] [Abstract][Full Text] [Related]
13. Comparative effectiveness of robot-assisted vs. open radical cystectomy. Hanna N; Leow JJ; Sun M; Friedlander DF; Seisen T; Abdollah F; Lipsitz SR; Menon M; Kibel AS; Bellmunt J; Choueiri TK; Trinh QD Urol Oncol; 2018 Mar; 36(3):88.e1-88.e9. PubMed ID: 29277584 [TBL] [Abstract][Full Text] [Related]
14. Impact of Packed Red Blood Cells and Fresh Frozen Plasma Given During Radical Cystectomy and Urinary Diversion on Cancer-related Outcome and Survival: An Observational Cohort Study. Furrer MA; Fellmann A; Schneider MP; Thalmann GN; Burkhard FC; Wuethrich PY Eur Urol Focus; 2018 Dec; 4(6):916-923. PubMed ID: 28951117 [TBL] [Abstract][Full Text] [Related]
15. Radical cystectomy versus trimodality therapy for muscle-invasive bladder cancer: a multi-institutional propensity score matched and weighted analysis. Zlotta AR; Ballas LK; Niemierko A; Lajkosz K; Kuk C; Miranda G; Drumm M; Mari A; Thio E; Fleshner NE; Kulkarni GS; Jewett MAS; Bristow RG; Catton C; Berlin A; Sridhar SS; Schuckman A; Feldman AS; Wszolek M; Dahl DM; Lee RJ; Saylor PJ; Michaelson MD; Miyamoto DT; Zietman A; Shipley W; Chung P; Daneshmand S; Efstathiou JA Lancet Oncol; 2023 Jun; 24(6):669-681. PubMed ID: 37187202 [TBL] [Abstract][Full Text] [Related]
16. Effect of diabetes mellitus and metformin use on oncologic outcomes of patients treated with radical cystectomy for urothelial carcinoma. Rieken M; Xylinas E; Kluth L; Crivelli JJ; Chrystal J; Faison T; Lotan Y; Karakiewicz PI; Sun M; Fajkovic H; Babjuk M; Bachmann A; Scherr DS; Shariat SF Urol Oncol; 2014 Jan; 32(1):49.e7-14. PubMed ID: 24140245 [TBL] [Abstract][Full Text] [Related]
17. Oncologic Outcomes for Patients with Residual Cancer at Cystectomy Following Neoadjuvant Chemotherapy: A Pathologic Stage-matched Analysis. Bhindi B; Frank I; Mason RJ; Tarrell RF; Thapa P; Cheville JC; Costello BA; Pagliaro LC; Karnes RJ; Thompson RH; Tollefson MK; Boorjian SA Eur Urol; 2017 Nov; 72(5):660-664. PubMed ID: 28545841 [TBL] [Abstract][Full Text] [Related]
18. Adjuvant Chemotherapy vs Observation for Patients With Adverse Pathologic Features at Radical Cystectomy Previously Treated With Neoadjuvant Chemotherapy. Seisen T; Jamzadeh A; Leow JJ; RouprĂȘt M; Cole AP; Lipsitz SR; Kibel AS; Nguyen PL; Sun M; Menon M; Bellmunt J; Choueiri TK; Trinh QD JAMA Oncol; 2018 Feb; 4(2):225-229. PubMed ID: 28837718 [TBL] [Abstract][Full Text] [Related]
19. Comparative Effectiveness of Trimodal Therapy Versus Radical Cystectomy for Localized Muscle-invasive Urothelial Carcinoma of the Bladder. Seisen T; Sun M; Lipsitz SR; Abdollah F; Leow JJ; Menon M; Preston MA; Harshman LC; Kibel AS; Nguyen PL; Bellmunt J; Choueiri TK; Trinh QD Eur Urol; 2017 Oct; 72(4):483-487. PubMed ID: 28412065 [TBL] [Abstract][Full Text] [Related]
20. Perioperative blood transfusion and radical cystectomy: does timing of transfusion affect bladder cancer mortality? Abel EJ; Linder BJ; Bauman TM; Bauer RM; Thompson RH; Thapa P; Devon ON; Tarrell RF; Frank I; Jarrard DF; Downs TM; Boorjian SA Eur Urol; 2014 Dec; 66(6):1139-47. PubMed ID: 25194909 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]